1-Cbz-4-Methylaminopiperidine is primarily utilized in organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various bioactive compounds, particularly in the synthesis of drugs targeting neurological and psychiatric disorders. The protective Cbz (carbobenzyloxy) group allows for selective reactions, making it valuable in peptide and heterocycle chemistry. Its structure is often exploited in the design of molecules with potential therapeutic effects, such as receptor modulators or enzyme inhibitors. Researchers also use it to study structure-activity relationships in drug discovery pipelines.